Editor's update: Emily Ashkin is featured in a podcast from The Lasker Foundation. My legs were starting to ache from standing by my research poster …
Ovarian cancer genetic testing is underused and large gene panels lead to uncertain results, particularly for non-white patients, a Stanford Medicine study finds.
A Stanford-developed anti-cancer therapy currently in clinical trials may also reduce vascular inflammation in heart disease.
In 2020, contributing editor Paul Costello’s top podcasts reflect the challenges of the coronavirus and other timely health care issues.
Stanford Medicine magazine's most-read articles of 2020 were about COVID-19, grieving and chemo brain, a misunderstood side effect of chemotherapy.
As younger adults are being diagnosed with colon cancer, the U.S. Preventive Services Task Force is recommending screening all adults older than 45.
ESPN told the story of Stanford football coach David Shaw donating stem cells to save his brother, who had a rare form of lymphoma.
Scientists have created an AI tool to help doctors more precisely choose colorectal cancer treatments that will work best on individual patients.
Stanford researchers studied whether there was any pattern linking patients' racial, ethnic or socioeconomic status with which treatment they received.
Stanford stem cell biologists have found a way to block a signal that causes growth of breast cancer cells, opening potential for new treatments.
Scientists created an algorithm that analyzes a cancer biopsy and pairs spatial information with gene expression to better understand the disease.
In breast and lung cancer patients with metastatic disease, seeds of metastasis were often planted before the primary tumor was diagnosed, a study finds.
Using microbubbles and ultrasound, researchers have created a cancer treatment that kills tumor cells and recruits immune cells to the tumor.
The experts on Stanford Medicine's molecular tumor board brainstorm new ways to attack individual patients' tumors at the genetic level.
Teens and young adults with cancer face biological and psychosocial challenges distinct from those of other cancer patients.
Stanford scientists have taken important steps toward figuring out how to use immune therapy for a group of severe pediatric brain tumors.